Lv31
310 积分 2024-04-25 加入
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
6小时前
待确认
An emerging strategy for targeted therapy of pulmonary arterial hypertension: Vasodilation plus vascular remodeling inhibition
29天前
已完结
Drugs targeting novel pathways in pulmonary arterial hypertension
1个月前
已完结
Anti-IgE therapy in chronic rhinosinusitis with nasal polyps
1个月前
已完结
Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps: SYNAPSE 24‐week treatment‐free follow‐up
1个月前
已完结
Primary testicular lymphoma
2个月前
已完结
Response to Glucocorticosteroids Predicts Olfactory Outcome After ESS in Chronic Rhinosinusitis
2个月前
已完结
Postmarketing Analysis of Eosinophilic Adverse Reactions in the use of Biologic Therapies for Type 2 Inflammatory Conditions
2个月前
已完结
Effectiveness and safety profile of mepolizumab in chronic rhinosinusitis with nasal polyps: Real life data in a tertiary care
2个月前
已完结
Comparison of Different Biologics for Treating Chronic Rhinosinusitis With Nasal Polyps: A Network Analysis
2个月前
已完结
皖公网安备34019202002308
